Despite rapid advances in the identification of genes involved in disease, the predictive power of the genotype remains limited, in part owing to poorly understood effects of secondsite modifiers. Here we demonstrate that a polymorphic coding variant of RPGRIP1L (retinitis pigmentosa GTPase regulatorinteracting protein-1 like), a ciliary gene mutated in MeckelGruber (MKS) and Joubert (JBTS) syndromes, is associated with the development of retinal degeneration in individuals with ciliopathies caused by mutations in other genes. As part of our resequencing efforts of the ciliary proteome, we identified several putative loss-of-function RPGRIP1L mutations, including one common variant, A229T. Multiple genetic lines of evidence showed this allele to be associated with photoreceptor loss in ciliopathies. Moreover, we show that RPGRIP1L interacts biochemically with RPGR, loss of which causes retinal degeneration, and that the Thr229-encoded protein significantly compromises this interaction. Our data represent an example of modification of a discrete phenotype of syndromic disease and highlight the importance of a multifaceted approach for the discovery of modifier alleles of intermediate frequency and effect.
Despite rapid advances in the identification of genes involved in disease, the predictive power of the genotype remains limited, in part owing to poorly understood effects of secondsite modifiers. Here we demonstrate that a polymorphic coding variant of RPGRIP1L (retinitis pigmentosa GTPase regulatorinteracting protein-1 like), a ciliary gene mutated in MeckelGruber (MKS) and Joubert (JBTS) syndromes, is associated with the development of retinal degeneration in individuals with ciliopathies caused by mutations in other genes. As part of our resequencing efforts of the ciliary proteome, we identified several putative loss-of-function RPGRIP1L mutations, including one common variant, A229T. Multiple genetic lines of evidence showed this allele to be associated with photoreceptor loss in ciliopathies. Moreover, we show that RPGRIP1L interacts biochemically with RPGR, loss of which causes retinal degeneration, and that the Thr229-encoded protein significantly compromises this interaction. Our data represent an example of modification of a discrete phenotype of syndromic disease and highlight the importance of a multifaceted approach for the discovery of modifier alleles of intermediate frequency and effect.
The ciliopathies are a collection of disorders with overlapping clinical manifestations, including renal cystic disease, polydactyly, retinal degeneration and defects of the central nervous system 1 , and provide a useful model to investigate both the effects of variation at a single locus and the potential epistatic interactions between alleles at functionally related loci. This is because several ciliopathy-causing genes can either cause a distinct recessive form of ciliary disease or contribute modulators of penetrance and expressivity. In some instances, multiple allelism at a single locus can partially explain phenotypic variability. For example, null mutations in NPHP3 cause MKS 2 , whereas hypomorphic NPHP3 alleles cause nephronophthisis (NPHP) 3 . Similarly, hypomorphic CEP290 (NPHP6) mutations are observed frequently in Leber congenital amaurosis (LCA) in both humans and in a mouse model 4, 5 , whereas loss-of-function mutations lead to a constellation of ciliopathies, including MKS, NPHP, BardetBiedl syndrome (BBS) and JBTS [6] [7] [8] [9] , without a clear explanation for the phenotypic variation.
Consistent with the suggestion of second-site modifiers, several alleles are reported to modify ciliary phenotypes; a hypomorphic mutation in CCDC28B contributes to the overall penetrance and expressivity of BBS 10 , and heterozygous variants in CEP290 and AHI1 contribute to the phenotypic severity and pleiotropy of NPHP 11 . Finally, likely additive effects between alleles in bona fide BBS and MKS loci produce hybrid phenotypes of the two clinical entities 7 .
A paradigm emerging from the above studies is that genes mutated in one ciliopathy may contribute alleles across the entire clinical spectrum and that the assessment of total mutational load across the ciliary proteome 12,13 will help dissect phenotypic causality and variability. Toward this end, we have initiated two complementary strategies-interactome studies on ciliary proteins and medical resequencing of known genes involved in ciliopathies across a cohort of individuals with diverse phenotypes (MKS and JBTS as severe, BBS as intermediate, NPHP and LCA as mild).
We first investigated RPGRIP1L, hypothesizing that, in addition to its association with MKS and JBTS 14, 15 , it might also contribute alleles to other ciliary disorders. We screened 166 unrelated individuals of northern European descent (17 MKS, 15 NPHP (with and without extrarenal phenotypes), 34 BBS, 100 LCA) and discovered ten different previously unknown nonsynonymous changes in 24 individuals ( Table 1) . We also detected two different common variants G1025S (rs2111119) and D1264N (rs3213758), both of which are present at similar allele frequencies when compared across our ciliopathy cohort, a cohort of 96 control individuals of northern European descent and 60 CEPH controls from HapMap (data not shown).
None of the observed alleles are sufficient to explain disease manifestation under a mendelian model. However, most alleles were either unique to our ciliopathy cohort, or were enriched compared to ancestry-matched controls, and mapped within known functional domains of RPGRIP1L ( Table 1 and Supplementary Fig. 1 online) . However, the rarity of most variants precluded us from investigating their potential impact on the clinical phenotypes. One notable exception, A229T, is sufficiently frequent to empower such a study. To assess allele neutrality without a preconceived model of inheritance, we carried out transmission disequilibrium testing (TDT): we screened 145 families with BBS for which DNA was available from both parents. Focusing on families in which only one of the two parents was an A229T heterozygote, we identified 18 informative trios and detected significant overtransmission of the threonine-encoding allele in affected individuals (15 of 18 transmissions; 83.3%, P o 0.01).
Despite the modest number of trios, the TDT suggested that the A229T change was not neutral. To probe this possibility further, we re-evaluated our original resequencing data. We found a marked Table 2 ). We therefore wondered whether this variant might contribute to the retinal defect, which is a frequent, but not ubiquitous, ciliopathy phenotype. If this is true, then comparisons between NPHP (no retinal degeneration) versus SLS cohorts (NPHP and retinal degeneration) should be informative. Even though each of these phenotypes is rare in the general population, we were able to study two northern European cohorts: 66 unrelated individuals with isolated NPHP and 84 individuals with SLS. We found that the allele encoding Thr229 was absent from the NPHP group, but was detected at an allele frequency of 5.4% in individuals with SLS ( Table 2 ). The small size of this cohort precluded meaningful statistical analysis. Nonetheless, these data suggested that the absence of Thr229 might have a protective effect from retinitis pigmentosa (RP).
To investigate this possibility, we asked whether the Thr229-encoding allele frequency was significantly different in a larger case-control cohort of ciliopathy-affected individuals of northern European descent (Supplementary Table 1 online). We categorized our subjects into two groups, with retinal phenotypes being the sole distinguishing factor. Both groups showed significantly different Thr229-encoding allele frequencies compared to controls (n ¼ 3,016 control alleles); the allele was absent from the nonretinal degeneration group (n ¼ 230 alleles; P ¼ 1.92E-03) but was enriched in the retinal degeneration group (combined: 4.5%, n ¼ 974 alleles, P ¼ 6.45EÀ03; Table 2 ). Furthermore, in agreement with our earlier data, we observed significantly different Thr229-encoding allele frequencies between the non-retinal pathology and retinal degeneration ciliopathy groups (P ¼ 7.35E-05; Table 2 ). To evaluate the statistical significance of our findings further, we carried out permutation analyses where the observed genotypes in the entire sample were assigned randomly without replacement in the three groups (ciliopathy with RP, ciliopathy without RP, controls). After 10 7 independent random assignments, we counted the number of times that the differences in minor allele frequency in each group matched or exceeded the actual differences. This study provided additional evidence that the association data did not occur by chance ( Table 2) . Notably, we found A229T to be transmitted through at least three different haplotypes (three subjects contained unique RPGRIP1L SNPs in cis with Thr229), and the frequency of Thr229 was indistinguishable across cohorts collected at different sites (Supplementary Table 1) , arguing against a stratification artifact. Our genetic data suggest a role for Thr229 in the development of RP in individuals affected with ciliopathies. However, the low frequency of this allele in the population and its apparent modest effect in our cohorts limit the power of genetic studies. We therefore evaluated the potential consequences of A229T on protein function.
As a first test, we carried out a genetic rescue experiment using an in vivo model. We have shown previously that suppression of ciliary and basal body proteins in zebrafish leads to measurable phenotypes in mid-somitic embryos, some of which are caused by defects in Wnt signaling 16, 17 , a phenotype also observed in other experimental ciliopathy models 18 . The ability of human mRNA to rescue somitic phenotypes has proven useful for establishing the pathogenic potential of alleles by comparing the efficiency of rescue of wild-type (wt) human messenger RNA (mRNA) compared to mRNA bearing the missense variant(s) under investigation 7 . We identified a single partial zebrafish transcript that, upon reciprocal BLAST analysis, showed the highest amino-acid similarity between zebrafish and human (73% similarity, 55% identity), and we designed a splice-blocking morpholino (MO) targeting this transcript. The morpholino was injected into wild-type embryos at the two-cell stage (50-100 embryos per injection) and scored at the eight-to nine-somite stage. Consistent with data from other ciliopathy genes 7,10,16,17 , we observed dose-dependent gastrulation defects, including a shortened body axis, thin somites with broad lateral extensions, minor kinking of the notochord, underdeveloped anterior structures and tail extension abnormalities, all of which enabled us to categorize embryos into two classes on the basis of objective criteria (class 1 or class 2, Fig. 1a and Supplementary Fig. 2a online) . These phenotypes resulted from loss of rpgrip1l, as RT-PCR and sequencing analysis of embryos showed 10 ng of MO to cause B50% reduction of rpgrip1l mRNA (Supplementary Fig.  2b) . Notably, the phenotypes could be rescued by co-injection of 50 pg of wt human mRNA (embryos scored blind to injection cocktails; Fig. 1b and Supplementary Table 2 online) .
We therefore proceeded to compare the efficiency of rescue between human mRNA encoding Ala229 versus Thr229. In addition, we included two known pathogenic missense variants, T615P and 
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, that cause JBTS 14, 15 as positive controls, as well as the neutral G1025S variant as a negative control. Embryos were co-injected with a cocktail of MO and each human mRNA (n ¼ 88-115 embryos per allele) and scored blind to the injection cocktail (Supplementary Table 2 ). We found that the Thr229 rescue gastrulation phenotype was significantly different from wt mRNA rescue (P o 0.0001; Fig. 1b and Supplementary Table 2 ). The assay was specific, as both T615P and A695P were scored as pathogenic, but had no off-target effects, as the rescue of the Ser1025-encoding mRNA was indistinguishable from that of the Gly1025 message (Fig. 1b) .
To quantify these assessments with objective criteria, we measured embryonic structures labeled in situ with pax2, krox20, and myoD riboprobes. On whole embryo flat-mounts age-matched to eight to nine somites, we calculated the ratio of the width (w) spanning the distal ends of the fifth somites to the length (l) of the notochord as demarcated by adaxial cell labeling (n ¼ 8-20 embryos measured per variant). Consistent with our live embryo scoring, comparison of the mean w/l ratios between wt and mutant rescues indicated that both positive-control variants and A229T, but not G1025S, were pathogenic (Fig. 1c,d and Supplementary Table 3 online).
As a third line of in vivo evidence, we examined 5-d rpgrip1l morphant larvae (n ¼ 52-78 embryos per injection). Consistent with other ciliopathy morphants 19 , we observed tail extension abnormalities in 35% of rpgrip1l morphants, which were rescued by co-injection of wt human RPGRIP1L message (Fig. 1e,f) . However, mRNA encoding Thr229 was unable to efficiently rescue the abnormal tail phenotype (P ¼ 0.031), consistent with both the T615P and A695P rescues (P ¼ 0.001 and 0.004, respectively). These observations, in addition to the absence of abnormal tail phenotypes in morphants rescued with G1025S mRNA, substantiated further the specificity of our assay (Fig. 1e,f) .
We next turned to the question of why A229T might have the observed effect on the retinal degeneration phenotype. We noted that mutations in one of the NPHP genes, NPHP5, are also associated with an increased incidence of SLS; all tested individuals with NPHP5 null variants show retinal degeneration compared to a 10% incidence of retinopathy in individuals with mutations in other NPHP-associated genes 20 . NPHP5 interacts with RPGR 20 , a ciliary protein mutated in 70-80% of X-linked RP and 20-25% of simplex RP [21] [22] [23] [24] . We therefore hypothesized that RPGRIP1L might also interact biochemically with RPGR and that the A229T allele might have a measurable effect on the affinity of this interaction. As part of our ongoing efforts to understand the pathobiology of RPGR, we had conducted yeast two-hybrid (Y2H) screens of human retinal cDNA as prey using full-length RPGR ORF15 as bait and identified the C-terminal domain of RPGRIP1L (RPGR-interacting domain; RID); this interaction was validated by known-bait and known-prey analysis using different domains of RPGR as bait (Fig. 2a,b) . To corroborate these findings, we generated an antibody to human RPGRIP1L ( Supplementary Fig. 3 online) and carried out co-immunoprecipitations using bovine retinal extracts. In reciprocal immunoprecipitation experiments with RPGRIP1L or RPGR antibody, we detected the expected bands on immunoblots corresponding to RPGR or RPGRIP1L, respectively (Fig. 2c) . Co-transfection of COS-1 cells followed by co-immunoprecipitation demonstrated that Xpress-tagged RPGR and GFP-RPGRIP1L proteins are part of the same complex (Fig. 2d) . We then tested A229T and three reported JBTS variants 14, 15 that were shown to be pathogenic in our zebrafish assay. Triplicate experiments showed that the GFP-tagged A229T mutant protein had considerably lower (B80%) ability to immunoprecipitate RPGR and had a profound effect on RPGR binding compared to the JBTS mutations (Fig. 2e,f) . We also found that RPGRIP1L localizes to the cilium and basal body of mouse IMCD3 cells and to the inner segment and connecting cilium of mouse photoreceptors ( Supplementary  Fig. 4 online) , in the same spatiotemporal context as demonstrated previously for RPGR 4, 23, 24 . Hence, the abrogation of RPGRIP1L-RPGR interaction is likely to be relevant in photoreceptors.
Second-site modifications are emerging as prevalent phenomena in mendelian disorders. For example, PLS3 is a protective modulator of SMN1 dysfunction associated with spinal muscular atrophy (SMA) 25 , mutations in CNTF modify the age of onset in amyotrophic lateral sclerosis (ALS) 26 , and a mutation in CCDC28B can modify the global penetrance and expressivity in BBS 10 . However, the penetrance and expressivity of tissue-specific defects within the context of syndromic disease pose a considerable challenge. This is especially true for alleles of modest frequency in the general population and modest effect on the phenotype, which cannot be captured by traditional populationbased genetic tools. Our data suggest that, in individuals of northern European descent, the presence of the Thr229-encoding allele of RPGRIP1L has predictive value for retinal degeneration. It will be important to consider the nature and position of mutations at the primary locus, as A229T probably exerts its effect in the context of mutations in genes encoding specific ciliopathy proteins that can complex with RPGR in the retina; this is consistent with the previously proposed poison model of genetic epistasis 27 .
It is possible that some of the other alleles reported herein might also show a similar effect; however, their rarity will necessitate the evaluation of larger cohorts. Notably, in vivo evaluation of each of the rare alleles using the zebrafish rescue assay suggested that most are pathogenic ( Table 3, Supplementary Tables 2 and 3 and Supplementary Fig. 5 online) and that they can potentially interact with alleles at various sites of the ciliopathy genetic spectrum ( Table 1) . Also, destabilization of the RPGRIP1L-RPGR complex is unlikely to be the sole cause of retinal degeneration. RPGRIP1L also associates with RPGRIP1 (Fig. 2c) , and null mutations in RPGRIP1 cause early-onset, severe retinal degeneration 28 . Three of the variants found in our cohort, A1183G, R1236C and D1264Y map within the RPGRIP1-interacting domain of RPGRIP1L; hence, their contribution to disease might be mediated by loss of RPGRIP1 activity or function. Finally, RPGRIP1L and RPGR are members of a larger macromolecular complex whose composition and function will vary across tissue types and ciliary functions. Establishment of the content and the stoichiometry of such complex(es), coupled to the evaluation of ciliopathy alleles on the stability of the macromolecular complex in a tissue-and function-dependent manner will enable the currently poor allelic stratification of variability in disease phenotypes.
METHODS
Ciliopathy cases, controls and mutational analysis. We obtained control DNAs from healthy individuals with no clinical ciliopathy criteria (retinal degeneration, polydactyly, renal abnormalities, mental retardation or other central nervous system defects) from four collection points (Supplementary Table 1 ). Blood samples were obtained following informed consent. We amplified the exon sequence and intron-exon junctions of RPGRIP1L from DNA extracted from lymphoblast cell lines or lymphocytes according to standard protocols. We sequenced PCR products with BigDye Terminator v3.1 chemistry on an ABI 3100 or ABI 3730 (Applied Biosystems), analyzed sequences with PolyPhred, and confirmed variants by resequencing and visual assessment of chromatograms. Primer sequences and PCR conditions are available upon request.
Statistical analyses. We used plink v1.04 for TDT analysis in BBS trios, and the PEPI404x package for Fisher's exact test. All other analyses were done in Microsoft Excel.
DNA constructs. We generated full-length or specific domains of RPGR by PCR from retinal cDNA and subcloned them into the pcDNA 4 expression vector (Invitrogen). Full-length RPGRIP1L was amplified from human retinal cDNA, cloned into expression vector pEGFP-C1 (in vitro assays) or pCS2+ (in vivo assays) and confirmed by direct sequencing. We conducted mutagenesis using the QuickChange Site-Directed Mutagenesis kit (Stratagene), according to manufacturer's instructions.
Zebrafish embryo manipulation and morpholino injection. A splice-blocking morpholino (MO) (Gene Tools) was diluted to appropriate concentrations in deionized, sterile water (2, 4, 6, 8 and 10 ng/nl for the dose response, and 10 ng/nl for rescue experiments) and was injected into wt zebrafish embryos at the two-cell stage as described 10 . To rescue the MO phenotype, we transcribed mRNA from linearized pCS2+-RPGRIP1L vector with the SP6 mMessage Machine kit (Ambion). We carried out in situ hybridization on whole embryos fixed with 4% paraformaldehyde with riboprobes against pax2, krox20 and myoD using standard protocols. Images were captured at Â10 magnification and measurements were taken of the width spanning the fifth somites from the anterior end, and the length of the notochord as defined by myoD staining of adaxial cells. Embryos used for assessment of tail phenotypes at 5 days postfertilization (dpf) were reared in 1-phenyl-2-thiourea (PTU)-treated embryo media, and anesthetized with Tricaine for imaging at Â4 magnification. MO efficiency was determined by extracting total RNA from embryos with Trizol (Invitrogen) according to manufacturer's instructions. Oligo-dTprimed total RNA was reverse transcribed using SuperScriptIII reverse transcriptase (Invitrogen) and cDNA was subsequently PCR amplified and sequenced using standard procedures.
Yeast two-hybrid screen. We carried out the yeast two-hybrid (Y2H) analysis using the Matchmaker Gal4-two hybrid system (Clontech), according to manufacturer's instructions. We amplified the full-length cDNA of mouse Rpgr ORF15 or its different domains and cloned into the bait vector pGBKT7. The adult human retinal cDNA library was cloned into the 'prey' pGADT7 vector (Clontech) and used for the screen. Known-bait and knownprey analysis was carried out as described 29 .
